Abstract
We have previously shown that the small heat shock protein HSP27 inhibited apoptotic pathways triggered by a variety of stimuli in mammalian cells. The present study demonstrates that HSP27 overexpression decreases U937 human leukemic cell sensitivity to etoposide-induced cytotoxicity by preventing apoptosis. As observed for Bcl-2, HSP27 overexpression delays poly(ADP-ribose)polymerase cleavage and procaspase-3 activation. In contrast with Bcl-2, HSP27 overexpression does not prevent etoposide-induced cytochrome c release from the mitochondria. In a cell-free system, addition of cytochrome c and dATP to cytosolic extracts from untreated cells induces the proteolytic activation of procaspase-3 in both control and bcl-2- transfected U937 cells but fails to activate procaspase-3 in HSP27- overexpressing cells. Immunodepletion of HSP27 from cytosolic extracts increases cytochrome c/dATP-mediated activation of procaspase-3. Overexpression of HSP27 also prevents procaspase-9 activation. In the cell- free system, immunodepletion of HSP27 increases LEDH-AFC peptide cleavage activity triggered by cytochrome c/dATP treatment. We conclude that HSP27 inhibits etoposide-induced apoptosis by preventing cytochrome c and dATP- triggered activity of caspase-9, downstream of cytochrome c release.
Original language | English |
---|---|
Pages (from-to) | 2061-2070 |
Number of pages | 10 |
Journal | FASEB Journal |
Volume | 13 |
Issue number | 14 |
DOIs | |
Publication status | Published - 1 Jan 1999 |
Keywords
- Apoptosis
- Cell death
- Drug resistance
- Etoposide
- Leukemia